| The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments JG Zhang, PE Czabotar, AN Policheni, I Caminschi, S San Wan, ... Immunity 36 (4), 646-657, 2012 | 376 | 2012 |
| Dendritic cells and cancer immunotherapy KJ Radford, KM Tullett, MH Lahoud Current opinion in immunology 27, 26-32, 2014 | 166 | 2014 |
| Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+ T cell recognition KM Tullett, IML Rojas, Y Minoda, PS Tan, JG Zhang, C Smith, R Khanna, ... JCI insight 1 (7), 2016 | 84 | 2016 |
| Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy B Zeng, APJ Middelberg, A Gemiarto, K MacDonald, AG Baxter, M Talekar, ... The Journal of clinical investigation 128 (5), 1971-1984, 2018 | 82 | 2018 |
| Differential uptake and cross‐presentation of soluble and necrotic cell antigen by human DC subsets MC Chiang, KM Tullett, YS Lee, A Idris, Y Ding, KJ McDonald, ... European journal of immunology 46 (2), 329-339, 2016 | 69 | 2016 |
| A natural peptide antigen within the plasmodium ribosomal protein RPL6 confers liver TRM cell-mediated immunity against malaria in mice AM Valencia-Hernandez, WY Ng, N Ghazanfari, S Ghilas, ... Cell host & microbe 27 (6), 950-962. e7, 2020 | 59 | 2020 |
| Glycolipid-peptide vaccination induces liver-resident memory CD8+ T cells that protect against rodent malaria LE Holz, YC Chua, MN de Menezes, RJ Anderson, SL Draper, ... Science immunology 5 (48), eaaz8035, 2020 | 56 | 2020 |
| Harnessing Human Cross-Presenting CLEC9A+XCR1+ Dendritic Cells for Immunotherapy KM Tullett, MH Lahoud, KJ Radford Frontiers in immunology 5, 239, 2014 | 50 | 2014 |
| Activation of human CD141+ and CD1c+ dendritic cells in vivo with combined TLR3 and TLR7/8 ligation FE Pearson, K Chang, Y Minoda, IML Rojas, OL Haigh, G Daraj, ... Immunology and cell biology 96 (4), 390-400, 2018 | 41 | 2018 |
| Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells KA Masterman, OL Haigh, KM Tullett, IM Leal-Rojas, C Walpole, ... Journal for immunotherapy of cancer 8 (2), 2020 | 33 | 2020 |
| Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1‐specific CD8+ T cells FE Pearson, KM Tullett, IM Leal‐Rojas, OL Haigh, KA Masterman, ... Clinical & translational immunology 9 (6), e1141, 2020 | 30 | 2020 |
| Display of native antigen on cDC1 that have spatial access to both T and B cells underlies efficient humoral vaccination Y Kato, TM Steiner, HY Park, RO Hitchcock, A Zaid, JL Hor, S Devi, ... The Journal of Immunology 205 (7), 1842-1856, 2020 | 22 | 2020 |
| RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells KM Tullett, PS Tan, HY Park, RB Schittenhelm, N Michael, R Li, ... Elife 9, e63452, 2020 | 17 | 2020 |
| Elucidating the Motif for CpG Oligonucleotide binding to the dendritic cell receptor DEC-205 leads to improved adjuvants for liver-resident memory J Li, F Panetta, M O’Keeffe, IM Leal Rojas, KJ Radford, JG Zhang, ... The Journal of Immunology 207 (7), 1836-1847, 2021 | 4 | 2021 |
| Abstract B125: Targeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy K Radford, F Pearson, KA Masterman, K Tullett, O Haigh, C Walpole, ... Cancer Immunology Research 7 (2_Supplement), B125-B125, 2019 | 2 | 2019 |
| Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad and durable systemic and mucosal immune responses NY Zhi Cheang, PS Tan, K Purushotorma, WC Yap, BY Leong Chua, ... bioRxiv, 2023.02. 21.529344, 2023 | 1 | 2023 |
| Targeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy KA Masterman, FE Pearson, K Tullett, O Haigh, C Walpole, G Daraj, ... Annals of Oncology 29, x35-x36, 2018 | 1 | 2018 |
| Targeting CLEC9A can deliver antigen to human CD141 (+) DC for recognition by both CD4 (+) and CD8 (+) T cells KM Tullett, IM Leal Rojas, Y Minoda, PS Tan, JG Zhang, C Smith, ... European Journal of Immunology 46, 820-820, 2016 | 1 | 2016 |
| Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice NYZ Cheang, KS Tan, PS Tan, K Purushotorma, WC Yap, KMI Tullett, ... Molecular Therapy, 2024 | | 2024 |
| A Simple and Rapid Protocol for the Isolation of Murine Bone Marrow Suitable for the Differentiation of Dendritic Cells R Song, M Bafit, KM Tullett, PS Tan, MH Lahoud, M O’Keeffe, AW Purcell, ... Methods and Protocols 7 (2), 20, 2024 | | 2024 |
